@JeahKJung Profile picture

JeahJung

@JeahKJung

Professor, Department of Health Administration and Policy, George Mason University

Joined July 2013
Similar User
Sungchul Park | 박성철 photo

@sungchul_p

William Schpero photo

@wschpero

David Meyers photo

@djmeyers2

Jessica Chang photo

@JessicaChang__

Brian McGarry photo

@McGarryBE

Lauren H. Nicholas photo

@lhnicholas

JVIR photo

@JVIRmedia

Joe Benitez photo

@j_a_benitez

Carrie H. Colla photo

@CHColla

Jing Li 李婧 photo

@JingLiUW

Kimberley H Geissler photo

@khgeissler

Cyrus Kosar photo

@cyruskosar

Wei Yang photo

@WeiYang11518835

Jun Li photo

@_JunLi_

Jeromie Ballreich photo

@jeromie_b

JeahJung Reposted

And thank you to @michaelannica and @NancyKeatingMD for their comments: jamanetwork.com/journals/jaman…


JeahJung Reposted

Notably, we saw no decrease in quality measures, including overall survival. Thanks to @JeahKJung for inviting me to collaborate on this important work! More to come soon...


JeahJung Reposted

Our new findings out in @JAMANetworkOpen this week - we find lower service utilization among cancer patients covered by Medicare Advantage vs. FFS Medicare: jamanetwork.com/journals/jaman…


JeahJung Reposted

New in HSR: "Requiem for Odds Ratios" with Bryan Dowd, Melissa Garrido, and Matt Maciejewski. onlinelibrary.wiley.com/toc/14756773/0… We commend HSR for discouraging the reporting of odds ratios in most studies. We agree wholeheartedly with this decision, which keeps HSR at the forefront.


JeahJung Reposted

...and found that Medicare Advantage appears more efficient, spending substantially less over a 6-month treatment episode. Differences driven by both lower intensity (fewer treatment days) and use of less-expensive drugs.


JeahJung Reposted

Looking forward to presenting this collaborative work with @JeahKJung &co at #ASCO24! We compared resource use (dollars spent) on cancer treatment between traditional Medicare and Medicare Advantage... meetings.asco.org/abstracts-pres…


JeahJung Reposted

New in @JAMAPsych with Emmanuel Greenberg, Susan Busch @marissadking jamanetwork.com/journals/jamap… We meticulously identified 1800+ private equity-owned outpatient mental health and substance use treatment clinics from 2012-2023.


JeahJung Reposted

MA markets with larger benchmark cuts absorbed the cuts without shrinking the MA market, suggesting that insurers maintained benefits valued by marginal enrollees. See the full paper + editorial for more: Editorial: jamanetwork.com/journals/jama-… Paper: jamanetwork.com/journals/jama-… (5/5)


JeahJung Reposted

Looking forward to presenting our new findings at #ASCO24! How much industry money do NCI cancer centers receive, relative to public/NCI funding? 🤔

Tweet Image 1

JeahJung Reposted

Looking forward to presenting findings on differences in cancer treatment between Medicare Advantage and Medicare FFS patients, with @JeahKJung & co on the team! #ASCO24

Tweet Image 1

JeahJung Reposted

How do Medicare outcomes differ among racial and ethnic groups? @JeanKJung of @GeorgeMasonU +coauthors explore differences in quality-of-care outcomes in Medicare and MA between minority and non-Hispanic White populations. Read the full study: bit.ly/4cp27Xo

Tweet Image 1

JeahJung Reposted

Excited to host @michaelannica at @MSKCancerCenter! Discussing this recent work on prior authorization, subject of my quoted tweet below. (MSK peeps who want to attend in person, email me!)

Tweet Image 1

For any docs out there who struggle with prior auth and would love to have your biases confirmed, I highly recommend this new study by @michaelannica @NancyKeatingMD, out yesterday in @JCO_ASCO: ascopubs.org/doi/full/10.12… 1/

Tweet Image 1


JeahJung Reposted

How much money does #Medicare waste each year on guideline-discordant bone therapy for prostate cancer? Our answer, reported this week in @JCOOP_ASCO: $43 million per year Even in the health care world, that ain't pocket change. ascopubs.org/doi/10.1200/OP… 🧵 1/


JeahJung Reposted

A holiday season publication! We find that infliximab and filgrastim biosimilar uptake from 2017-2019 is consistently higher in MA compared to TM, and that Kaiser HMO plans drive those differences. @dr_msocal @KellyAnders0n, Andrew Xuan, & Jerry Anderson jmcp.org/doi/full/10.18…


JeahJung Reposted

Future oncology health services researchers - Great new opportunity for protected research time while working at the world's greatest cancer center! Put this post-doc at @MSKCancerCenter on your radar!

Tweet Image 1

JeahJung Reposted

Pharmacy Benefit Managers (#PBM): How did they emerge? What do they do? How should we evaluate policy proposals that regulate them? @GeBaiDC, David Hyman, & I discuss in @JAMAHealthForum (Thread 12/12) jamanetwork.com/journals/jama-…


JeahJung Reposted

Did you know hospitalization and ER visit rates differ quite a bit among home- and community-based service vs nursing facility service users, depending on where you live? For more information, read our paper: journals.sagepub.com/doi/10.1177/10… #LTC #aging #Medicaid


Loading...

Something went wrong.


Something went wrong.